ask="N/A"
ask_size="N/A"
average_daily_volume="27192"
bid="N/A"
bid_size="N/A"
book_value="0.2800"
change="+0.0499"
change_from_200_day_moving_average="-0.2306"
change_from_50_day_moving_average="-0.0028"
change_from_52_week_high="-0.9200"
change_From_52_week_low="0.1399"
change_in_percent="+8.3167%"
close="0.6499"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.2600"
ebitda="-2.11M"
eps_estimate_current_year="-0.0200"
eps_estimate_next_quarter="0.0000"
eps_estimate_next_year="-0.0200"
ex_dividend_date="N/A"
float_shares="9122000"
high="0.6499"
high_52_weeks="1.5699"
last_trade_date="1/31/2017"
last_trade_price="0.6499"
last_trade_size="400"
last_trade_time="4:00pm"
low="0.5800"
low_52_weeks="0.5100"
market_capitalization="8.71M"
moving_average_200_day="0.8805"
moving_average_50_day="0.6527"
name="XTL Biopharmaceuticals Ltd. - A"
notes="N/A"
one_year_target_price="6.0000"
open="0.5830"
pe_ratio="N/A"
peg_ratio="0.0000"
percent_change_from_200_day_moving_average="-26.1906%"
percent_change_from_50_day_moving_average="-0.4331%"
percent_change_from_52_week_high="-58.6025%"
percent_change_from_52_week_low="+27.4314%"
previous_close="0.6000"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.1429"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="13400000"
short_ratio="0.4000"
stock_exchange="NCM"
symbol="XTLB"
volume="30973"
weeks_range_52="0.5100 - 1.5699"
